News Releases

PDI, Inc. Names Christopher Tama Executive Vice President and General Manager, Diversified Teams Business

SADDLE RIVER, N.J. (June 23, 2005) PDI, Inc. (Nasdaq: PDII), a diversified sales and marketing services company serving the biopharmaceutical and medical devices and diagnostics industries, is pleased to announce that Christopher Tama has been appointed to the role of Executive Vice President and General Manager, Diversified Teams. In this role, Mr. Tama will be responsible for the strategic plan and overall management of PDI's Select Access™ and medical devices and diagnostics (MD&D) business units.

“I am very excited about the sales force alternative Select Access offers pharmaceutical manufacturers,” Mr. Tama said. “As the need to maximize the return on all of the products in their portfolios increases, innovative solutions will be required. Select Access is perfectly aligned to increase incremental revenue for mature brands, OTC brands, and for specialty brands that could gain an additional revenue stream from a primary care presence. Select Access also is a viable solution for emerging companies, providing a scalable sales force as they grow their brands.”

“We are also tremendously excited about the opportunity to bring new sales solutions to the medical devices and diagnostics industry,” Mr. Tama continued. “This market has not traditionally outsourced their sales efforts, but as devices are increasingly developed and used in the treatment of chronic diseases such as depression, hypertension and diabetes, among others, MD&D companies are looking for cost effective means to reach larger physician target audiences. We are in a strong position because we can leverage the operational learnings gained from years of experience serving the pharmaceutical industry, but can also customize our service offerings to meet the unique needs of this market segment.”

Steven K. Budd, President of PDI, added, “We are very pleased to have someone with Chris’ pedigree leading these two critically important business units. We are confident that under Chris’ leadership PDI will continue its tradition of pioneering new sales solutions to serve the biopharmaceutical and MD&D industries.”

Mr. Tama is a 25-year veteran in the pharmaceutical industry, holding executive management leadership roles at several major pharmaceutical companies. While serving as Vice President of the CNS Therapeutic Area franchise at Novartis, he led his unit to become the third largest CNS portfolio in the world and launched several new therapies. As Vice President of Marketing, US Operations for Searle, he was responsible for the US product portfolio including Calan SR, Daypro, Ambien, Arthrotec and Cytotec. Mr. Tama started his pharmaceutical career at Pharmacia, holding sales and marketing positions of increasing responsibility, including a 3 year assignment at the company’s headquarters in Uppsala, Sweden as a member of an international product marketing launch team. Prior to his new role at PDI, Mr. Tama held leadership positions as Executive Vice President and General Manager of PDI Pharmaceutical Products Group and as Executive Vice President of Strategic Acquisitions.

About PDI

PDI, Inc. (NASDAQ:PDII) is a diversified sales and marketing services provider to the biopharmaceutical and medical device and diagnostics industries. PDI’s comprehensive set of next-generation solutions is designed to increase its clients’ strategic flexibility and enhance their efficiency and profitability. Headquartered in Saddle River, NJ, PDI also has offices in Pennsylvania and Illinois.

PDI’s sales and marketing services include dedicated, shared, clinical and combination sales teams; marketing research and consulting; medical education and communications; talent recruitment; and integrated commercial solutions from pre-launch through patent-expiration. The company’s experience extends across multiple therapeutic categories and includes office and hospital-based initiatives.

PDI’s commitment is to deliver innovative solutions, excellent execution and superior results to its clients. Through strategic partnership and client-driven innovation, PDI maintains some of the longest sales and marketing relationships in the industry. Recognized as an industry pioneer, PDI continues to innovate today as a thought-starter for the outsourcing of sales and marketing services.

For more information, visit the Company’s website at www.pdi-inc.com.

About Select Access

Select Access, a targeted sales solution for a diverse group of pharmaceutical products, leverages an existing infrastructure to maximize brand profitability. Rapid deployment and national coverage by 400 experienced sales representatives in high prescribing territories increases speed to impact. Select Access is the only alternative sales force model that gives clients complete target audience control and flexibility and where the majority of sales calls are single detail.

Select Access’ unmatched value is perfectly aligned to increase incremental revenue for mature brands, OTC brands, and for specialty brands that could gain an additional revenue stream from a primary care presence. Select Access also is a viable solution for emerging companies, providing a scalable sales force as they grow their brands.

For more information, visit the website at www.select-access.com.

About Medical Devices and Diagnostics Teams

PDI Medical Devices and Diagnostics Teams, a sales solutions business unit for the medical devices and diagnostics market segment, provides customized sales and clinical teams to drive incremental revenue growth for manufacturers. Leveraging the operational learnings of an outsourced sales company, PDI MD&D Teams builds sales teams to manufacturers’ specifications: target profiles of the representatives, target audience universe and sales and marketing performance metrics are determined by the client.

PDI MD&D Teams also provides clinical teams of clinical nurse educators and medical technicians and technologist to drive after-sales pull-through. Closely linked with the business development process, these teams ensure customer satisfaction and compliance.

Copyright © Select Access, a division of PDI, Inc. • Information Privacy Policy

About Select Access | Markets Served | Press & Media | Target Coverage Analysis | Contact Us | PDI, Inc.